The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Welcome,         Profile    Billing    Logout  
 10 Trials 
11 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liu, Li
ART Study, NCT06242041: The Effect of Potassium Lowering Drugs on Cardiac Electrical Stability in Hemodialysis Patients

Recruiting
4
61
RoW
sodium zirconium cyclic silicate, hemodialysis
Peking University First Hospital
Potassium Imbalance, Cardiac Arrhythmia, Dialysis; Complications
12/24
12/24
NCT06350890: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

Active, not recruiting
3
408
RoW
HTD1801, berberine ursodeoxycholate, Placebo
HighTide Biopharma Pty Ltd
T2DM (Type 2 Diabetes Mellitus)
03/25
09/25
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder

Recruiting
3
1041
RoW
YZJ-1139 20mg, YZJ-1139 40mg, Placebo
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Insomnia Disorder
12/24
12/24
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

Active, not recruiting
3
878
RoW
JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy
Shanghai Junshi Bioscience Co., Ltd.
Gastric or Esophagogastric Junction Adenocarcinoma
06/26
07/28
Haplo-HSCT, NCT06202625: Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After

Recruiting
2/3
142
RoW
avatrombopag, Doptelet, Placebo
Peking University People's Hospital, Xiangya Hospital of Central South University, Sichuan Provincial People's Hospital, First Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xinjiang Medical University, Shanxi Bethune Hospital, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Tang-Du Hospital, The First Affiliated Hospital of Nanchang University
Thrombocytopenia, Stem Cell Transplant Complications
10/24
10/25
NCT04317248: "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma

Recruiting
2
600
RoW
Cyclophosphamide, Endoxan, Multiple Signals loaded Dendritic Cells Vaccine, MSDCV
Yuehua Huang, Sun Yat-sen University, Nanfang Hospital of Southern Medical University
Hepatocellular Carcinoma
04/22
04/22
NCT04983043: Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure

Completed
2
228
RoW
Low dose QiShen YiQi Dripping Pills 3 bags, Low dose group, High dose QiShen YiQi Dripping Pills 3 bags, High dose group, QiShen YiQi Dripping Pills placebo 3 bags, Placebo group
Tasly Pharmaceutical Group Co., Ltd
Chronic Heart Failure With Reduced Ejection Fraction
11/24
11/24
NCT05024214: Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Recruiting
1/2
170
RoW
Lenvatinib + Envafolimab, Sunitinib
3D Medicines (Sichuan) Co., Ltd.
Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma
12/24
12/24
PreMAO, NCT06184347: Population-wide Research for HBV-related Liver Diseases in Maoming City

Not yet recruiting
N/A
3700000
NA
Rapid tests for HBsAg, Laboratory examination of sample of blood, Imaging examination
Nanfang Hospital, Southern Medical University
HBV Infection, Chronic Hepatitis B, Cirrhosis, HCC
03/25
08/25

Recruiting
N/A
3000
US
Treatment Recommendation Surveys, 7-gene biosignature
PreludeDx, University of South Florida
DCIS
12/25
12/35
Zhang, Yuehui
NCT04833881: Proteomics/Modifier Based on Mass Spectrometry Reveals the Pathogenesis of Eclampsia During Pregnancy and the Screening of Disease Markers

Recruiting
N/A
100
RoW
Heilongjiang University of Chinese Medicine
Mechanism, Marker Screening
11/24
11/24

Download Options